| Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3) A Lespine, J Dupuy, S Orlowski, T Nagy, H Glavinas, P Krajcsi, ... Chemico-biological interactions 159 (3), 169-179, 2006 | 150 | 2006 |
| Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2 A Pal, D Mehn, E Molnar, S Gedey, P Meszaros, T Nagy, H Glavinas, ... Journal of Pharmacology and Experimental Therapeutics 321 (3), 1085-1094, 2007 | 130 | 2007 |
| The Gβγ dimer drives the interaction of heterotrimeric Gi proteins with nonlamellar membrane structures O Vögler, J Casas, D Capó, T Nagy, G Borchert, G Martorell, PV Escribá Journal of Biological Chemistry 279 (35), 36540-36545, 2004 | 122 | 2004 |
| Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors E Kis, E Ioja, T Nagy, L Szente, K Heredi-Szabo, P Krajcsi Drug Metabolism and Disposition 37 (9), 1878-1886, 2009 | 119 | 2009 |
| Membrane structure modulation, protein kinase Cα activation, and anticancer activity of minerval J Martínez, O Vögler, J Casas, F Barceló, R Alemany, J Prades, T Nagy, ... Molecular pharmacology 67 (2), 531-540, 2005 | 117 | 2005 |
| Recovery of glass fibre and carbon fibres from reinforced thermosets by batch pyrolysis and investigation of fibre re-using as reinforcement in LDPE matrix JA Onwudili, N Miskolczi, T Nagy, G Lipóczi Composites Part B: Engineering 91, 154-161, 2016 | 105 | 2016 |
| Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance E Kis, T Nagy, M Jani, É Molnár, J Jánossy, O Ujhellyi, K Német, ... Annals of the rheumatic diseases 68 (7), 1201-1207, 2009 | 94 | 2009 |
| On translanguaging and its role in foreign language teaching T Nagy Acta Universitatis Sapientiae, Philologica 10 (2), 41-53, 2018 | 80 | 2018 |
| Receptor-like properties of the 26 kDa transmembrane form of TNF A Domonkos, A Udvardy, L László, T Nagy, E Duda European cytokine network 12 (3), 411-9, 2001 | 70 | 2001 |
| Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs A Lespine, J Dupuy, M Alvinerie, C Coméra, T Nagy, P Krajcsi, S Orlowski Current drug metabolism 10 (3), 272-288, 2009 | 63 | 2009 |
| Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study G Rubovszky, I Láng, E Ganofszky, Z Horváth, E Juhos, T Nagy, E Szabó, ... European Journal of Cancer 49 (18), 3806-3812, 2013 | 55 | 2013 |
| Calcein assay: a high-throughput method to assess P-gp inhibition H Glavinas, O Von Richter, K Vojnits, D Mehn, I Wilhelm, T Nagy, ... Xenobiotica 41 (8), 712-719, 2011 | 50 | 2011 |
| Ivermectin interacts with human ABCG2 M Jani, I Makai, E Kis, P Szabó, T Nagy, P Krajcsi, A Lespine Journal of pharmaceutical sciences 100 (1), 94-97, 2011 | 49 | 2011 |
| English as a lingua franca and its implications for teaching English as a foreign language T Nagy Acta Universitatis Sapientiae, Philologica 8 (2), 155-166, 2016 | 44 | 2016 |
| Competitiveness-higher education I Labas, E Darabos, TO Nagy Studia Universitatis „Vasile Goldis” Arad–Economics Series 26 (1), 11-25, 2016 | 40 | 2016 |
| Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy A Bebes, T Nagy, Z Bata-Csörgő, L Kemény, A Dobozy, M Széll Journal of Photochemistry and Photobiology B: Biology 105 (2), 162-166, 2011 | 37 | 2011 |
| Parvalbumin-and calbindin-containing neurons express c-fos protein in primary and secondary (mirror) epileptic foci of the rat neocortex A Mihaly, M Szente, Z Dubravcsik, B Boda, E Kiraly, T Nagy, A Domonkos Brain research 761 (1), 135-145, 1997 | 36 | 1997 |
| G protein–membrane interactions I: Gαi1 myristoyl and palmitoyl modifications in protein–lipid interactions and its implications in membrane microdomain localization R Álvarez, DJ López, J Casas, V Lladó, M Higuera, T Nagy, M Barceló, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2015 | 33 | 2015 |
| Synergistic effect of Avemar on proinflammatory cytokine production and Ras‐mediated cell activation A Telekes, E KISS‐TÓTH, T Nagy, EE Qwarnstrom, E Kusz, T Polgar, ... Annals of the New York Academy of Sciences 1051 (1), 515-528, 2005 | 31 | 2005 |
| Flow cytometric cytotoxicity assay for measuring mammalian and avian NK cell activity C Vizler, T Nagy, E Kusz, H Glavinas, E Duda Cytometry: The Journal of the International Society for Analytical Cytology …, 2002 | 31 | 2002 |
